|
|
|
Insider
Information: |
Deerfield Special Situations Fund International Lt |
Relationship: |
Possible Members of 10... |
City: |
Road Town, Tortola |
State: |
D8 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
130,000 |
|
Indirect Shares
|
19,698,472 |
|
|
Direct
Value |
$330,500 |
|
|
Indirect Value
|
$142,629,703 |
|
|
Total
Shares |
19,828,472 |
|
|
Total
Value |
$142,960,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
21
|
4
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
21
|
1
|
|
|
|
Gain/Loss Ratio : |
-21.0
|
3.0
|
Percentage
Gain/Loss : |
-30.4%
|
-70.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dynavax Technologies Corp |
DVAX |
Possible members of 10... |
2006-03-03 |
0 |
2006-10-04 |
2,035,137 |
Premium* |
|
ISTA Pharmaceuticals Inc |
ISTA |
Possible members of 10... |
2006-06-01 |
80,000 |
2006-06-01 |
2,791,863 |
Premium* |
|
Par Pharmaceutical Companies Inc |
PRX |
10% Owner |
2007-02-01 |
15,000 |
2007-02-01 |
2,173,177 |
Premium* |
|
Corautus Genetics Inc |
VEGF |
Possible Member of 10%... |
|
0 |
2007-11-06 |
1,244,708 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2008-11-19 |
881,743 |
Premium* |
|
Neurogesx Inc |
NGSX |
10% Owner |
|
0 |
2009-07-13 |
987,880 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
10% Owner |
2008-10-18 |
0 |
2008-10-18 |
904,903 |
Premium* |
|
Neurometrix Inc |
NURO |
Possible Members of 10... |
|
0 |
2010-12-14 |
781,833 |
Premium* |
|
Nxstage Medical, Inc. |
NXTM |
10% Owner |
2009-12-15 |
10,000 |
2009-12-15 |
3,694,836 |
Premium* |
|
Talon Therapeutics Inc |
TLON |
Possible Members of 10... |
|
0 |
2012-07-05 |
136,849 |
Premium* |
|
Fibrocell Science Inc |
FCSC |
Possible Members of 10... |
2010-08-16 |
0 |
2010-08-16 |
1,162,800 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
Possible Members of 10... |
2010-11-03 |
25,000 |
2010-11-03 |
2,902,743 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VEGF |
Corautus Genetics Inc |
10% Owner |
|
2007-10-23 |
4 |
S |
$3.97 |
$397 |
I/I |
(100) |
1,295,890 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
10% Owner |
|
2007-10-24 |
4 |
S |
$3.91 |
$51,542 |
I/I |
(13,167) |
1,287,568 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
10% Owner |
|
2007-10-25 |
4 |
S |
$3.88 |
$8,330 |
I/I |
(2,149) |
1,286,209 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
Possible Member of 10% Group |
|
2007-10-26 |
4 |
S |
$3.92 |
$9,052 |
I/I |
(2,307) |
1,284,750 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
Possible Member of 10% Group |
|
2007-10-31 |
4 |
S |
$3.97 |
$460 |
I/I |
(116) |
1,284,676 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
Possible Member of 10% Group |
|
2007-11-05 |
4 |
S |
$3.38 |
$338 |
I/I |
(100) |
1,284,612 |
0 |
- |
|
VEGF |
Corautus Genetics Inc |
Possible Member of 10% Group |
|
2007-11-06 |
4 |
S |
$3.21 |
$202,673 |
I/I |
(63,138) |
1,244,708 |
0 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
10% Owner |
|
2008-10-18 |
4 |
S |
$2.18 |
$1,002,800 |
I/I |
(460,000) |
904,903 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
|
2008-11-13 |
4 |
S |
$0.48 |
$128,298 |
I/I |
(261,930) |
1,200,832 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
|
2008-11-14 |
4 |
S |
$0.49 |
$17,787 |
I/I |
(36,300) |
1,177,454 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
|
2008-11-18 |
4 |
S |
$0.44 |
$24,084 |
I/I |
(54,464) |
1,142,379 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
|
2008-11-19 |
4 |
S |
$0.24 |
$97,310 |
I/I |
(388,793) |
881,743 |
0 |
- |
|
NXTM |
Nxstage Medical, Inc. |
10% Owner |
|
2009-06-12 |
4 |
S |
$5.96 |
$161,385 |
I/I |
(27,078) |
1,771,770 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-06-22 |
4 |
S |
$5.90 |
$234,540 |
I/I |
(35,783) |
1,410,522 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-06-23 |
4 |
S |
$6.05 |
$218,519 |
I/I |
(35,887) |
1,387,267 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-06-24 |
4 |
S |
$5.73 |
$67,123 |
I/I |
(11,657) |
1,379,713 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-06-26 |
4 |
S |
$5.86 |
$1,520,957 |
I/I |
(259,549) |
1,211,524 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-06-30 |
4 |
S |
$5.99 |
$94,426 |
I/I |
(15,764) |
1,201,277 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-07-06 |
4 |
S |
$5.90 |
$145,134 |
I/I |
(24,599) |
1,185,287 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-07-07 |
4 |
S |
$5.96 |
$177,912 |
I/I |
(29,851) |
1,165,883 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-07-08 |
4 |
S |
$5.89 |
$80,658 |
I/I |
(13,694) |
1,156,981 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-07-09 |
4 |
S |
$5.97 |
$59,700 |
I/I |
(10,000) |
1,150,480 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Possible Member of 10% Group |
|
2009-07-13 |
4 |
S |
$5.97 |
$1,493,407 |
I/I |
(250,152) |
987,880 |
0 |
- |
|
NXTM |
Nxstage Medical, Inc. |
10% Owner |
|
2009-09-11 |
4 |
S |
$6.97 |
$719,012 |
I/I |
(103,148) |
952,446 |
0 |
- |
|
NXTM |
Nxstage Medical, Inc. |
10% Owner |
|
2009-09-14 |
4 |
S |
$6.71 |
$431,422 |
I/I |
(64,060) |
1,637,747 |
0 |
- |
|
148 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|